суббота, 20 сентября 2014 г.

International symposium on geroprotectors

International symposium on geroprotectors:
Practical Applications of Aging Research for Drug Discovery (free registration)

http://www.agingpharma.org 

https://www.facebook.com/agingpharma?notif_t=page_invite_accepted

The symposium will comprise into the three sessions relevant to the drug discovery companies. Each session will be chaired by the top expert in the field: 
Session I: Predicting the activity of geroprotective drugs: in-silico screening, omics data analysis and rational drug design
Session II: Drugs with the potential geroprotective properties
Session III: Aging Biomarkers: how do we measure aging and geroprotective efficacy?

Session IV: Trends in Aging Research and Drug Discovery.

My dearest friends, please note the schedule update for the Practical Applications of Aging Research for Drug Discovery forum in Basel. Registration is Free. Please use the interactive meeting planner at www.miptec.ch . For more information and forum schedule you may see http://www.agingpharma.org/2014/09/important-forum-schedule-update.html


The forum is organized by Alex Zhavoronkov, PhD  (The Biogerontology Research Foundation, UK) and Bhupinder Bullar, PhD (Novartis Pharma AG, Switzerland)


 It is interesting to note that forum collect so many briliant scientists in one place such as:

Brian Kennedy PhD, Director, CEO, Buck Institute for Aging Research
Charles Cantor PhD, Professor, Boston University
Nir Barzilai, Director, Albert Einstein College of Medicine

Joan Mannick, PhD, Director, Translational Medicine, Novartis Institute for Biomedical Research

Anton Buzdin, PhD, DSc, President, CEO, Pathway Pharmaceuticals, Hong Kong

Joao Pedro De Magalhaes, PhD, Lab Head, University of Liverpool

Alexander Zhavoronkov, PhD, Director, The Biogerontology Research Foundation, CEO, Insilico Medicine, Inc 

Robert Molinari, PhD, CEO, Retrotope, Inc

Dr. Joerg Reinhardt, Chairman of the Board of Directors, Novartis

Alexey Moskalev, PhD,

DScBhupinder Bhullar, PhD

William Bains, PhD, Head of the SENS Laboratory, Cambridge

Sven Bulterijs, PhD, Post-grad researcher, Yale University

Olga Kovalchuk, PhD, Professor, Lab Head, University of Lethbridge, Director, Canada Cancer and Aging Research Laboratories

Mikhail Blagosklonny, MD, PhD, Professor, Editor-in-Chief of Aging, Cell Cylcle and Oncotarget high-impact journals, Rosewell Park, NY

Blanka Rogina, PhD, Director Genetics & Developmental Biology Graduate Program, University of Connecticut

James Kirkland, MD, PhD, Professor, Mayo Clinic

Barry Merriman, PhD, Professor, UCLA / Lead System Architect, CSO, Thermo Fisher Scientific     

Alexander Bürkle, PhD, Professor, EU MARK-AGE Co-ordinator, University of Konstanz

Vadim Gladyshev, PhD, Professor, Department of Medicine, Harvard Medical School, Director of Redox Medicine, Medicine, Brigham And Women's Hospital, Harvard

Antonei Benjamin Csoka, PhD, Assoc. Professor, Howard University, CEO, Vision Genomics, Inc

Richard Faragher, Professor, University of Brighton 

Geoffrey Furlonger, CEO, Aging Analytics, Charles Groome, Head of Communications, Aging Analytics UK

Dmitry Kaminskiy, Director, Senior Partner, Deep Knowledge Ventures

David Brindley, Research Fellow , Harvard University of Oxford


Комментариев нет:

Отправить комментарий